79257-61-7Relevant articles and documents
Heterocyclic compounds as FGFR4 inhibitors
-
Paragraph 0127; 0138-0142, (2021/02/10)
The present invention provides heterocyclic compounds as selective inhibitors of fibroblast growth factor receptor 4 (FGFR4), pharmaceutical compositions containing the compounds, methods of preparingthe compounds, and methods of treating cell proliferative diseases, such as cancer, using the compounds of the invention.
Concentration-Dependent Thermal Isomerization of Nitrile N-Oxide
Bando, Shiho,Koyama, Yasuhito,Takata, Toshikazu
, (2020/08/13)
Kinetically stabilized nitrile N-oxides (NOs) have been regarded as viable tools for the postpolymerization functionalization of common polymers. However, thermal isomerization of NO to isocyanate restricts the applications of NO to industrial use. The re
Substituent effects in solid-state assembly of activated benzotriazoles
Wenholz, Daniel S.,Bhadbhade, Mohan,Kandemir, Hakan,Ho, Junming,Kumar, Naresh,Black, David Stc.
, p. 835 - 842 (2019/02/05)
Aromatic donor-acceptor stacking involving electron-rich π-donors and electron-deficient π-acceptors has been utilized in a broad spectrum of diverse applications to great effect. We report the discovery of unprecedented donor-acceptor stacking from a non